Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine

European Journal of Clinical Pharmacology

Volumn 50, Issue 3, 1996, Pages 203-208

  Madsen, J K ^a   Jensen, J D ^a   Jensen, L W ^a   Pedersen, E B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cyclosporine, felodipine; Dehydrofelodipine, pharmacokinetics, blood pressure, drug interaction

Indexed keywords

4 (2,3 DICHLOROPHENYL) 2,6 DIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID ETHYL METHYL ESTER; CALCIUM ANTAGONIST; CYCLOSPORIN A; DRUG METABOLITE; FELODIPINE; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AREA UNDER CURVE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FELODIPINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 0030001079     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050093     Document Type: Article

References (33)

1. Ahnoff M (1984) Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Analysis 2:519-526
2. Awni WM, Kasiske BL, Heim-Duthoy K, Rao KV (1989) Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism. Clin Pharmacol Ther 45:41-48
3. Bailey DG, Arnold JM, Munoz C, Spence JD (1993) Grapefruit juice felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 53:637-642
4. Berg KJ, Holdaas H, Endresen L, Fauchald P, Hartmann A, Pran T, Solbu D (1991) Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients. Nephrol Dial Transplant 6:725-730
5. Blychert E, Wingstrand K, Edgar B, Lidman K (1990) Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets. Br J Clin Pharmacol 29:39-45
6. Bourbigot B, Guiserix J, Airiau J, Bressollette L, Morin JF, Cledes J (1986) Nicardipine increases cyclosporin blood levels [letter]. Lancet 1:1447
7. Brockmoller J, Neumayer HH, Wagner K, Weber W, Heinemeyer G, Kewitz H, Roots I (1990) Pharmacokinetic interaction between cyclosporin and diltiaxem. Eur J Clin Pharmacol 38: 237-242
8. Clark S, Fowlie S, Coats A, Radaelli A, van-der-Putt M, Bird R, Conway J (1991) Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations. J Hum Hypertens 5:77-82
9. Copur MS, Tasdemir I, Turgan C, Yasavul U, Caglar S (1989) Effects of nitrendipine on blood pressure and blood ciclosporin A level in patients with posttransplant hypertension. Nephron 52:227-230
10. Dunselman PH, Edgar B (1991) Felodipine clinical pharmacokinetics. Clin Pharmacokinet 21:418-430
11. Dy GR, Raja RM, Mendez MM (1991) The clinical and biochemical effect of calcium channel blockers in organ transplant recipients on cyclosporine. Transplant Proc 23:1258-1259
12. Endresen L, Bergan S, Holdaas H, Pran T, Sinding-Larsen B, Berg KJ (1991) Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients. Ther Drug Monit 13:490-495
13. Gomez DY, Wacher VJ, Tomlanovich SJ, Hebert MF, Benet LZ (1995) The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin Pharmacol Ther 58:15-19
14. Guengerich FP, Brian WR, Iwasaki M, Sari MA, Baarnhielm C, Berntsson P (1991) Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. J Med Chem 34:1838-1844
15. Guengerich FP, Kim DH (1990) In vitro inhibition of dihydropyridine oxidation and aftatoxin Bl activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 11:2275-2279
16. Hasselgren B, Ronn O, Edgar B, Johansson P, Wall B (1990) Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet. Cardiovasc Drugs Ther 4:1495-1500
17. Howard RL, Shapiro JI, Babcock S, Chan L (1990) The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients. Ren Fail 12:89-92
18. Jacolot F, Simon I, Dreano Y, Beaune P, Riche C, Berthou F (1991) Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol 41:1911-1919
19. Lindholm A, Henricsson S, Dahlqvist R (1990) The effect of food and bile acid administration on the relative bioavailability of cyclosporin. Br J Clin Pharmacol 29:541-548
20. Lindholm A (1991) Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit 13:465-477
21. Miniscalco A, Lundahl J, Regardh CO, Edgar B, Eriksson UG (1992) Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 261:1195-1199
22. Nyberg G, Haljamae U, Herlitz H, Norden G, Blohme I (1994) Early renal graft function in recipients treated with the calcium channel blocker felodipine. Scand J Urol Nephrol 28: 17-20
23. Pedersen EB, Sorensen SS, Eiskjaer H, Skovbon H, Thomsen K (1992) Interaction between cyclosporine and felodipine in renal transplant recipients. Kidney Int [Suppl] 36:S82-S86
24. Ptachcinski RJ, Venkataramanan R, Burckart GJ, Gray JA, Van-Thiel DH, Sanghvi A, Rosenthal JT (1987) Cyclosporine kinetics in healthy volunteers. J Clin Pharmacol 27:243-248
25. Renton KW (1985) Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. Biochem Pharmacol 34:2549-2553
26. Schlanz KD, Myre SA, Bottorff MB (1991) Pharmacokinetic interactions with calcium channel antagonists (Part I). Clin Pharmacokinet 21:344-356
27. Sturrock ND, Lang CC, Struthers AD (1993) Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man. J Hypertens 11:1209-1216
28. Tortorice KL, Heim-Duthoy KL, Awni WM, Rao KV, Kasiske BL (1990) The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients. Ther Drug Monit 12:321-328
29. Wagner K, Henkel M, Heinemeyer G, Neumayer HH (1988) Interaction of calcium blockers and cyclosporine. Transplant Proc 20:561-568
30. Wahlberg J, Hanas L, Bergstrom C, Fellstrom B, Skarp-Orberg I, Frodin L (1992) Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients. Transplant Proc 24:311-322
31. Watkins PB (1990) The role of cytochromes P-450 in cyclosporine metabolism. J Am Acad Dermatol 23:1301-1309; discussion
32. Wiinberg N, Nygart J, Sengelov H, Nielsen PE (1988) [Oscillometric determination of blood pressure]. Ugeskr Laeger 150: 1282-1284
33. Wolf BA, Daft MC, Koenig JW, Flye MW, Turk JW, Scott MG (1989) Measurement of cyclosporine concentrations in whole blood: HPLC and radioimmunoassay with a specific monoclonal antibody and 3H-or 125I-labeled ligand compared. Clin Chem 35:120-124